Abstract
INTRODUCTION
A complete aortic root replacement using biological (BB) or mechanical (MB) valve conduits is the treatment of choice for patients with aortic valve and proximal ascending aorta pathology requiring surgery [1] [2] [3] . Both prosthetic valve types have some advantages and disadvantages. For mechanical prosthesis, the main problem is the lifelong need for anticoagulants, while the main benefit is the durability. Conversely, biological prosthesis does not require a prolonged anticoagulation therapy but are more prone to structural valve deterioration over time.
Primary end-points of the present study were to compare, within a population of over 1100 patients, biological versus mechanical composite valve grafts in terms of early and late postoperative mortality and morbidities comprising the risk of aortic redo.
PATIENTS AND METHODS

Study population and analytical plan
From 1978 to 2011, 1112 patients underwent aortic root replacement using composite valve grafts at Sant'Orsola Hospital, Bologna, Italy. Mean age of the entire population was 58.8 ± 13.7 years and 893 (80.3%) were male patients. Our institutional review board approved the study. Data were obtained using a prospective database supplemented by chart review.
After matching the patients for 29 variables (23 preoperative and 6 relevant intraoperative characteristics) using statistical methods controlling for treatment selection bias (see Statistical Analysis section), we obtained 2 analogous cohorts of 138 patients for mechanical Bentall (MB group) and biological Bentall (BB group) procedure (Fig. 1) . Indications for root surgery were mainly due to chronic degenerative aneurysm (117, 84.8% in MB and 104, 75.4% in BB) and a previous cardiac operation was reported in 10.1% of the mechanical and in 8.0% of the biological root replacements. A bicuspid aortic valve was identified in 30.4% of MB and 29.7% of the BB population. In the entire matched population, an urgent or emergent operation was necessary in 29 (10.5%) cases. All details of the 2 matched groups are listed in Table 1 .
Surgical techniques
The operative technique has previously been described in detail [1] . Routinely, a standard median sternotomy was performed. Cardiopulmonary bypass was instituted by cannulation of the ascending aorta, arch, femoral, brachiocephalic and axillary arteries depending on the extension of the aneurysm and the presence of dissection. Myocardial protection was achieved with cold crystalloid cardioplegia and topical cooling with 4 C saline solution. In our earlier operations, the inclusion and wrapping technique was used [2] . In 1994, we abandoned the original Bentall procedure and began the 'button technique' known also as 'modified Bentall procedure' [3, 4] . In case of difficult coronary mobilization such as extreme aortic dilatation or reoperation, the Cabrol technique [5] was preferred (7 patients, 2.5%). Since 2000 we have implanted biological conduits, initially 'home-made', obtained by combining biological valve prosthesis with the tube graft and then using composite graft prosthesis. The choice of tissue valve (pericardial/porcine, stented/stentless) was driven individually each time according to the root anatomy and patient needs. Since 2007 the Valsalva Vascutek graft (Terumo, Renfrewshire, Scotland, UK) was routinely adopted in all the procedures. The biological valve was chosen in the place of a mechanical valve on the basis of patient age: patients >65 years and those with contraindications to anticoagulation were usually recommended to have a tissue valve. Instead, patients aged <60 years received a mechanical valve unless they were adversely affected by anticoagulation therapy or if they refused for personal reasons (e.g. pregnancy, noise, etc.). Patients with a biological valve were advised to take warfarin daily only for the first 3 months and then to continue with acetylsalicylic acid. Only 18 patients (13.0%) of the entire BB group required continuing on anticoagulant treatment mostly because of a previous history or a new persistent atrial fibrillation at follow-up. All patients with mechanical valves were treated with warfarin, at a target international normalized ratio of 2.0 to 3.0.
Follow-up
Of all the hospital survivors (258 patients), 257 (99.6%) were available for follow-up. Mean follow-up time for the overall matched population was 40 ± 38 months (ranging from 1 month to 222.3 months), and, in particular, it was 51 ± 46 for MB and 29 ± 25 for BB. The patients were followed through an examination process in our outpatient clinic, which included a computed tomography/magnetic resonance imaging review, direct telephone interview of the patient or a close relative and by civil registry.
Statistical analysis
Continuous variables were expressed as mean ± SD or median and categorical variables as percentages. Student's t-test and Mann-Whitney U-test were used for continuous variables. Pearson's v 2 or Fisher's exact test was used for categorical variables.
From a non-parsimonious multivariable logistic regression with Bentall techniques as the dependent variable, a propensity score (PS) was derived from the estimated probability that a given patient would undergo BB or MB procedure; it incorporated 23 preoperative (gender, age, urgent/emergent status, hypertension, diabetes, obesity, smoking, chronic obstructive pulmonary disease, renal failure, bicuspid aortic valve, Marfan syndrome, NYHA Class III/IV, coronary artery disease, cerebrovascular disease, peripheral vascular disease, ejection fraction of the left ventricle <50% and redo operations and 6 surgical indications as degenerative aneurysm, acute aortic dissection, chronic post-dissection aneurysm, false aneurysm, endocarditis and aortic valve prosthesis dysfunction) and 6 intraoperative (3 associated thoracic aorta procedures as root alone, arch, elephant trunk/frozen elephant trunk and 3 other associated procedure as coronary artery bypass grafting, mitral valve repair/replacement and tricuspid valve repair) relevant covariates as the independent variable. Patients undergoing MB were matched on a one-on-one basis, with patients undergoing BB on the basis of PS, by the use of nearest-neighbour matching without replacement, and a matching tolerance (caliper) of 0.1 (Supplementary Material, Figs S1 and S2). To control for treatment selection biases, the PS for each patient was used as an adjusting variable in the binary logistic regression model and the Cox regression model. Long-term survival was investigated using Kaplan-Meier analysis and differences in survival and freedom from reintervention between groups were examined with the log-rank test.
Univariate analyses were performed to determine relationships between measured variables and in-hospital mortality and follow-up mortality. Root prosthesis type and variables that achieved P-values <0.05 in the univariate analyses were introduced in stepwise logistic regression to estimate the independent effects of risk factors for hospital mortality and in Cox regression to estimate the independent effects for all-cause mortality and aortic reoperation at follow-up. P-values <0.05 were considered statistically significant. Statistical analysis was performed using Statistical Package for Social Sciences version 22.0 (IBM SPSS Inc., Chicago, IL, USA).
RESULTS
Operative data
Associated surgical procedures and operative times are listed in Table 2 .
Some differences in the operative data were observed in the 2 matched groups. Two hundred and fifty-five patients (92.4%) underwent a modified 'button technique' Bentall procedure. The classic Bentall and the Cabrol operations were performed only in the MB population in 14 (10.1%) and 6 (4.3%) patients, respectively, except for 1 patient in the BB group (0.7%). Associated surgical procedures for the thoracic aorta (arch replacement, classic elephant and frozen elephant trunk procedures) were included in the PS analysis and therefore were not statistically different between groups.
The biological root reconstruction required a longer myocardial ischaemia time (131 ± 35.6 min vs 121 ± 37.9 min; P = 0.02) but similar cardiopulmonary bypass time (168 ± 59.6 min vs 160 ± 63.3 min; P = 0.3) compared with the MB.
In-hospital outcomes
Overall in-hospital mortality (including death occurring after the range of 30 postoperative days) was 6.5% (18 of 276 patients). In particular, it was 7.2% in the MB and 5.8% in the BB without significant statistical difference (P = 0.6). This finding was also confirmed after adjusting for the propensity-matched population [odds ratio (OR): 0.79; 95% confidence interval (CI): 0.34-2.01; P = 0.6]. Moreover, the multivariate analysis revealed that preoperative ejection fraction (OR: 5.21; 95% CI: 1.10-24.43, P = 0.04), NYHA functional class (OR: 3.14; 95% CI: 1.32-7.12, P = 0.009) and the cardiopulmonary bypass time (OR: 1.02; 95% CI: 1.01-1.024, P = 0.001) were independent predictors of hospital mortality.
Postoperative complications are listed in Table 3 . No differences in terms of acute myocardial infarction, neurologic damages (transient ischaemic attack, stroke and paraplegia) and renal failure were observed between the BB and MB groups. Chest reopening for bleeding was similarly required after surgery (OR: 2.30, 95% CI: 0.78-6.82, P = 0.2). Length of stay in the intensive care unit (7 ± 37.7 days for MB and 4 ± 7.6 for BB, P = 0.3) and in the hospital (14 ± 31.2 days for MB and 13 ± 13.5 for BB, P = 0.8) was also similar.
Survival and late morbidities
Forty-three patients died at follow-up, and causes of death are described in Table 4 . Cumulative survival at 1, 5 and 7 years was 95.1 ± 1.9%, 83.7 ± 4.2% and 75.0 ± 5.7%, respectively, for MB group and 99.2 ± 0.8%, 87.3 ± 3.5% and 83.6 ± 4.9%, respectively, for BB group (log-rank P = 0.9, Fig. 2A) .
Propensity-adjusted Cox-regression analysis (Table 5) showed no relationship between the type of prosthesis and all-cause mortality at follow-up [hazrads ratio (HR): 0.88; 95% CI: 0.50-2.14; P = 0.4]. The only independent predictor of late mortality was a previous cardiac operation before surgery (HR: 6.41; 95% CI: 1.41-29.48; P = 0.02).
Freedom from haemorrhagic (98.1 ± 1.3% for MB and 100% for BB at 7 years), thromboembolic (98.3 ± 1.2% for MB and 97.1 ± 2.1% for BB at 7 years) and cerebral embolism (94.3 ± 3.0% for MB and 97.3 ± 2.0% for BB at 7 years) events as well as endocarditis (99.2 ± 0.8% for MB and 83.6 ± 4.9% for BB at 7 years) are shown in Fig. 3 . None of the previous mentioned complications were found to be statistically significant between groups.
Aortic reoperation
Seven patients required a reoperation for aortic reasons during the entire follow-up time: 1 of 128 in the MB group and 6 of 129 in the BB group. Surgical replacement of the descending thoracic aorta for progressive dilatation was necessary in 1 patient. Infective endocarditis was the leading cause of the proximal aortic reoperations in 5 of 6 (4 affecting the BB) patients and all cases required an extensive aortic root replacement often using a complete biologic tissue. A pseudoaneurysm occurred in 1 patient (1 of 6) 3 years after the first composite aortic root replacement with a St. Jude Medical Epic prosthesis (St. Jude Medical, Inc., St Paul, MN, USA). At multivariate Cox-regression analysis (Table 5) infective endocarditis was the only independent predictor for proximal aortic redo (HR: 48.66; 95% CI: 8.80-69.79; P < 0.001) among all the risk factors, including the use of bioprosthesis conduit, considered in the statistical model.
Freedom from proximal aortic reoperation at 1, 5 and 7 years was equally 99.1 ± 0.9% for MB group and 98.4 ± 1.1%, 93.0 ± 3.2% and 93.0 ± 3.2%, respectively, for BB group (log-rank P = 0.07, Fig. 2B ).
DISCUSSION
The efficacy of the modified Bentall-De Bono procedure for the treatment of aortic root diseases has consolidated over the years [ [1] [2] [3] [4] [5] [6] [7] . Like other open aortic procedures, meticulous planning and standardization of the procedure provides excellent results [7] [8] [9] [10] . Its successful feature is also the wide applicability in various aortic pathologies. The goal of this study was to determine whether there are any differences in the early and/or late outcomes using the 2 options commercially available for mechanical versus biological valve conduits. Starting from the idea that both types of prosthesis are inclined to have known limitations (lifelong anticoagulation for the MB and structural valve deterioration for the BB), we tried to investigate the potential therapeutic benefit of these 2 available options when the aortic root replacement was required. Based on the retrospective nature of this study, a PS analysis was adopted to strengthen causal inferences of the population [10] . Using this statistical tool, it was possible to create 2 homogeneous groups for comparison (276 patients from 1112 patients), including all preoperative and relevant intraoperative variables influencing the outcomes.
Review of these retrospective data began with the analysis of early outcomes. In-hospital mortality was 6.5% in the matched population (18 of 276) without statistical differences between groups (OR 0.79, P = 0.6). Given the complexity of our interventions (>15% underwent arch repair, conventional or a frozen elephant trunk and 9.1% were reoperations) and the patients' risk profile, we believe that early adverse events are overestimated and in line with those reported by others [6, [11] [12] [13] . An example is the recent meta-analysis by Mookhoek et al. [6] reporting 7629 patients from 46 different studies, where early mortality was 5.6% and patient profiles were similar to ours.
We were unable to find any important differences in the occurrence of early complications between the mechanical and biological aortic root replacement as temporary dialysis, stroke and myocardial infarction were 3.6% vs 7.2%, 1.4% vs 2.9% and 3.6% vs 3.6%, respectively. Unsurprisingly, the multivariate analysis also confirmed that the choice of the Bentall did not adversely affect early mortality.
The most interesting evidence coming from the comparison of these 2 populations concerns the results obtained at follow-up. After matching the preoperative variables using PS, we obtained for the MB and the BB patients 2 groups with a mean age of 65 and 66 years, respectively. In the current era of increasingly early implantation of tissue valves, it appeared very interesting to compare. With all the limitations coming from our midterm analysis, survival was comparable between the 2 matched populations during the whole study period (at 5 years it was 83.7 ± 4.2% for MB vs 87.3 ± 3.5% for BB, log-rank P = 0.9). According to this finding, the Cox-regression analysis also confirmed that the type of Bentall did not influence late death (HR, 0.88; P= 0.4).
In a similar series, Etz et al. [14] showed no difference in longterm survival of a non-matched population of 307 biological and 290 mechanical root procedures (relative risk: 0.9, P= 0.74). They found in the 50-to 70-year-old age group of patients an age >65 years, coronary artery disease and clot to be independent risk factors for late mortality. On the contrary, in our matched groups, we were able to identify only previous cardiac operations to be a predictor for late mortality (HR: 6.41; P= 0.02). The limited follow-up period of this study, the relative young population and the careful clinical and radiological follow-up were all probable factors that directly influenced and mitigated the occurrence of adverse events. Freedom from proximal aortic reoperation at 7 years was encouraging and similar for MB and BB patients (99.1% vs 93.0%, long-rank P = 0.07). The main cause of late reoperations was prosthetic valve endocarditis. The only patient with a pseudoaneurysm formation of the proximal suture line underwent a successful reoperation. In order to reduce the incidence of this complication, in 1994, we abandoned the original Bentall procedure introducing the button technique, which also facilitated the procedure in case of reoperations [3, 4, 15] .
Infective endocarditis was confirmed as a serious cause of aortic reintervention (5 of the 6 aortic root redos at follow-up), and it was the only cause independently related at logistic regression analysis (HR: 48.66; P < 0.001). Although it may not be a statistically significant difference, this complication mostly affected the bioprosthetic valves (MB = 1 and BB = 5; P = 0.2) within 1 year of surgery (early onset). Beyond 1 year, it was very rarely and equally observed in both groups, which means that the early trend towards the BB was probably not directly related to the type of aortic graft. Every time a prosthesis valve endocarditis was diagnosed, it required an aggressive management to limit deleterious complications. In this series, 1 patient was successfully treated with appropriate antibiotic therapy and followed up with seriated echocardiographic examination, while 5 required extensive aortic root replacement usually with a complete biological conduit (100% of survival rate).
Considering the relative short follow-up available after propensity matching, neither age nor the type of prosthesis increased the rate of reoperation in the midterm. Our results confirmed what has previously been reported by the group of Leipzig in Germany [16] . They compared early and late outcomes of stentless porcine xenoroot (n = 78) and mechanically valved composite prosthesis (n = 127) in young patients between 50 and 60 years. Freedom from aorta-related reoperation at 12 years was not different between the groups (porcine: 94.9% vs mechanical: 96.1%; P = 0.73). Furthermore, the authors similarly recorded adverse events, such as cerebrovascular events and bleeding, during the follow-up. We had no valve-related complications in our study, and the occurrence of major bleedings (P = 0.1), embolic complications (P = 1) and stroke (P = 0.5) was not statistically different between the mechanical and biological prosthesis.
Similarly, Byrne et al. [17] previously reported equal 5-year freedom from valve-related complications with biological and mechanical aortic root replacements (93% vs 86%, respectively) and low occurrence of late postoperative complications in the entire population (3.9% stroke, 2.4% endocarditis, 1.9% bleeding and 3.1% reoperation). Our study confirmed and strengthened these results because it is based on a similarly long follow-up (mean 40 ± 38 vs 39 ± 28 months), it involves an older population (65 vs 54 years) and especially because the groups were matched using a PS analysis.
It is very intriguing that despite the use of oral anticoagulation required for mechanical valve prosthesis, no association was evident regarding the occurrence of major bleeding and thromboembolic complications at follow-up. In a series of 528 Dutch patients, van Putte et al. [18] recommend aortic root replacement with mechanical valve prosthesis as the first-choice treatment for aortic root pathology in younger patients. They reported a 14.6% incidence of thromboembolic events (based on 75% of the population) during the entire long-term follow-up. Our results showed a lower rate of bleeding (3.1%) and embolic (1.6%) complications, which may reflect contemporary strategies on lowering international normalized ratio especially for recently available prosthesis and self-management of anticoagulation therapy by the patients.
Our analysis may provide new evidence for valve selection. Firstly, the Bentall procedure, regardless of the prosthesis used, provides a standardized method to safely replace the aortic root in different aortic pathologies and clinical conditions. It was also recently confirmed in a paper from our institution [7] . Secondly, in patients aged >65 years either an MB or a BB procedure may be reasonably offered, inasmuch as valve-related complications and need for reoperation are relatively low and comparable (until 7 years). Finally, mechanical valve root replacement could guarantee a long-life treatment with a low incidence of thromboembolic complications for the patient after hospital discharge.
Limitations
The lack of randomization and the retrospective design are the most critical limitations of the study. Propensity analysis is a powerful statistical technique but is limited by the number and accuracy of the assessed variables. However, it has to be said that in our analysis, a considerable number of preoperative covariates were used to compute the PS, and post-matching covariate balance was excellent. Furthermore, it will be arduous to obtain randomized controlled trials enrolling patients of different age and presenting different aortic pathologies, which is the reason why observational studies remain important to compare different operative techniques. Another important limitation of the study is the shorter follow-up period available for the tissue valve conduits (implantation started in 2000). This means it may be too early to discuss long-term results (structural valve degeneration usually occurs after a period of 10-15 years); and therefore, a longer follow-up is needed to validate these results.
CONCLUSIONS
The Bentall procedure is confirmed as a landmark treatment for aortic root and ascending aorta pathologies.
Starting with comparable preoperative characteristics, both biological and mechanical composite valve grafts offer almost identical midterm survival and valve-related events.
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